PMDA drug package insert
メンタム
PMDA OTC drug · 白石薬品株式会社 · package insert May 11, 2023
Key facts
| Brand names | メンタム |
|---|---|
| Companies | 製造販売元／株式会社雪の元本店,販売会社／白石薬品株式会社 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 塗布剤 |
| OTC effect category | 鎮痛・鎮痒・収れん・消炎薬（パップ剤を含む） |
| Package insert date | May 11, 2023 |
| PMDA document key | 820021_J0901000088 |
| PMDA company code | 820021 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: